Journals / Türk Geriatri Dergisi / 2004 / Cilt: 7 - Sayı: 1

The distribution of atherosclerosis and operation mortality in elderly diabetic patients who underwent coronary artery bypass surgery

Koroner arter bypass ameliyatı olan yaşlı diyabetik hastalarda ameliyat mortalitesi ve koroner ateroskleroz dağılımı

Pages
15–20
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, it is neccessary to agresively treat the diabetes and additional risk factors especially before the CABG.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronary artery bypass surgery (CABG) may be the most suitable choice in between the unattractive alternatives for the diabetic and elderly patients.
📊
Key Findings & Data:Although age is a well known mortality risk factor for the patients who underwent CABG, increasing number of patients are operated with an acceptable risks.
💡
Conclusion & Impact:In conclusion, it is neccessary to agresively treat the diabetes and additional risk factors especially before the CABG.
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Coronary artery bypass surgery (CABG) may be the most suitable choice in between the unattractive alternatives for the diabetic and elderly patients. Although age is a well known mortality risk factor for the patients who underwent CABG, increasing number of patients are operated with an acceptable risks. This study is planed to investigate the risk factors for the diabetic patients and atherosclerotic lesion distribution due to age. Between 1986 and 2003, a total of 328 patients with diabetes mellitus were underwent CABG at Türkiye Yüksek Ihtisas Hospital, Ankara, Turkey. Of these patients, who were below the age 45, were considered as group 1 (161 patients) and who were above the age 70, were considered as group 2 (167 patients). 30.4 % of the patients in group 1 and 11.4 % of the patients in group 2 had one-vessel disease. Postoperative inotropic and mechanical support, vasodilator usage were higher in group 2. Low cardiac output was diagnosed in 3.1 % and 16 % in group 1 and 2 respectively. Postoperative myocardial infarction, major neurolojic events and infection were seldomly observed and all were included in group 2. The operation, cross-clamp and cardiopulmonary bypass time were longer in group 2. Hospital mortality were found as 1.2 % in group 1 (2 patients) and 16.8 % in group 2 (28 patients). Atheroscleroic lesion distribution was different accoring to different coronary arteries. Left main coronary artery disease was determined 5.6 % and 8.4 % in groups 1 and 2. Circumflex artery branches and right coronary artery lesions were differed according to groups and they were diffusely found in group 2. In conclusion, it is neccessary to agresively treat the diabetes and additional risk factors especially before the CABG.

Özet

Koroner arter bypas cerrahisi cazip olmayan seçenekler içinde bazen yaşlı ve diyabetik hastalar için en uygun olanı olabilir. İleri yaş koroner arer bypas greftelemesi (KABG) sonrası mortalite için bilinen bir risk olmaka birlikte artık daha fazla ileri yaşta hasta kabul edilebilir risklerle ameliyat olmak üzere kliniklere başvurmaktadır. Bu çalışma yaşlı ve diyabetik hastalar da genç-diyabetik hastalara göre mortalite ve diğer risk faktörlerinin karşılaştırmasını ve koroner aterosklerotik lezyonların dağılımlarındaki farklııkları araştırmak için planlanmıştır. Türkiye Yüksek İhtisas Hastanesi, Kalp ve Damar Cerrahisi Kliniğinde 1986-2003 yılları arasında koroner arter bypass ameliyatı yapılan, diyabet tanısı konmuş veya kanşekeri 120 mg/dl üzerinde olan, 45 yaş altı veya 70 yaş ve üzeri, 328 hasta çalışmaya dahil edilmiştir. Hastaların 161'i 45 yaş ve altı (grup 1), 167'i 70 yaş ve üzeri (grup 2) olmak üzere 2 grup oluşturularak veriler incelendi. Ameliyat sonrası inotropik, vazodilatör ve mekanik destek kullanımı grup 2 de anlamlı olarak daha yüksekti. Yoğun bakımda postoperatif MI, majör nörolojik olay ve enfeksiyon her 2 grupta da az olmakla beraber mevcut komplikasyonların tümü 2. grupta tespit edildi. Hastane mortaliesi grup 1 de, 2 hasta ile % 1.2, grup 2 de, 28 hasta ile % 16.8 olarak hesaplandı. Hastaların aterosklerotik lezyon dağılımları ise bazı koroner damarlarda farklılıklar gösteriyordu. Sol ana koroner lezyonu % 5.6 ve % 8.4 olarak grup 1 ve 2 de görülmekle gruplar arasında anlamlı fark yoktu. Obtus-marjin dalları, ve sağ koroner lezyonları grup 2 de anlamlı olarak azla sıklıkta idi. Sonuç olarak, özellikle KABG yapılması planlanan yaşlı-diyabetik hastalarda artan mortalite ve morbidite önemlidir. Diyabet ve diğer ek risk aktörlerinin agresive tedavisine gerek vardır.

🔖

Cite This Article

TÜTÜN, U., AKSÖYEK, A., TEMÜRTÜRKAN, M., KATIRCIOĞLU, S. F., ÇOBANOĞLU, A., BUDAK, B., KUTSAL, A., ULUS, A. T. (2022). The distribution of atherosclerosis and operation mortality in elderly diabetic patients who underwent coronary artery bypass surgery. Türk Geriatri Dergisi, Cilt: 7 - Sayı: 1, 15–20. https://ajindex.com/articles/624375

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Karaaslan Y. Romatizmal hastal›klar tedavi el kitab›. MD Yay›nc›l›k, Ankara, 2003; pp 34-44
  2. Maurer K. Basic data on arthritis: knee, hip, and sacroiliac joint, in adults aged 25-74 years: United States. 1971-1975. National Center for Health Statistics Series 11-Number 213. DHEW Publ. No. (PHS) 79-1661. Washington (DC): Public Health Service, US Government Printing Office: 1979
  3. Balazs EA, Denlinger JL. Viscosupplementation: A new concept in the treatment of asteoarthritis. J Rheumatol 1993; 20 (Suppl 39): 2-9
  4. Scott JE. Hyaluronan, multum in parvo. Eur J Rheumatol Inflamm 1995; 15: 3-8
  5. Balazs EA. The physical properties of synovial fluid and the special role of hyaluronic acid. In: Helfet A, ed. Disorders of the Knee. Second edition. JB Lippincott. Philadelphia, 1982; pp 61-74
  6. Hochberg MC, Chang RW, Dwash I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35: 498-502
  7. Kellgren J, Lawrance J. Atlas of Standard Radiographs: The Epidemiology of Chronic Rheumatism. Blackwell Scientific. Oxford, 1963
  8. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt L. Validation study of WOMAC: A health status measure for measuring clinically important patient relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheumatol 1988; 1: 95- 108
  9. Likert R. A technique for measurement of attitudes. Arch Psychol 1932; 140: 44-60
  10. Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2002; 162: 292-298
  11. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial. J Rheumatol 1998; 25: 2203-2212
  12. Grecomoro G, Martorana U, Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: A controlled clinical trial versus placebo. Pharmatherapeutica 1987; 5: 137-141
  13. Dixon ASJ, Jacoby RK, Berry H, Hamilton EBD. Clinical trial of intra articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 1988; 11: 205-13
  14. Bragantini A, Cassini M, De Bastiani G, Perbellini A. Controlled single-blind trial of intra-articularly injected hyaluronic acid (Hyalgan) i